NDC 48433-161-01 - ezetimibe
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-161
- Requested NDC
- 48433-161-01
- Package NDCs from labels
- 48433-161-01, 48433-161-03
- Manufacturer
- Safecor Health, LLC
- Effective date
- 2026-09-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ezetimibe - Safecor Health, LLC | Safecor Health, LLC | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| EZETIMIBE | EZETIMIBE | Accord Healthcare Inc. | ceecdbe9-5404-4a93-a488-9211cd103058 | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | American Health Packaging | 0e9a9eda-1b2a-4475-8483-0f410a17c524 | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | A-S Medication Solutions | 4cfda5aa-e21a-47b2-b296-88d8336298ef | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | A-S Medication Solutions | 4158aa71-3540-4912-b909-7491e5a1429c | 2025-10-14 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | dd8a09cb-f014-4650-9da2-4ad1581c9741 | 2025-10-10 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Dr.Reddys Laboratories Inc | 023ca87a-1b04-8c17-dc4f-e2758b0771e2 | 2025-07-18 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | c92292f5-5444-4247-927e-db7bf6816109 | 2025-07-17 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Ascend Laboratories, LLC | 206d702c-b09a-4555-972b-6555d6d6d6e6 | 2025-06-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | 3a80b668-51cd-42be-8497-8712b0508422 | 2025-05-12 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Ascend Laboratories, LLC | c90e8c96-e130-42d7-bf0d-5833652e40d5 | 2025-05-02 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Aurobindo Pharma Limited | 726b1e63-437a-4b3b-b773-3ac47a5c0f38 | 2025-03-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | NorthStar Rx LLC | 5f5644a9-e019-4e5d-ab6f-3d30b1024c5a | 2025-03-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | 55b18d8f-40e0-48ba-baf1-79a0d1bb2ee2 | 2025-03-01 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Walgreens Soothing Eye Relief Lubricant Eye Drops | POLYVINYL ALCOHOL, POVIDONE | Walgreens Co. | 29b7387b-ad65-3a11-e063-6394a90a6a15 | 2025-02-14 | Warnings | FZ989GH94E |
| Ezetimibe | EZETIMIBE | Amneal Pharmaceuticals NY LLC | 3fadf4e9-017d-4ccd-91dc-a89b981eb138 | 2025-02-10 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.